XML 49 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 6 - Net Income Per Share
9 Months Ended
May 31, 2014
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]

6.Net Income Per Share


The Company calculates net income per share in accordance with US GAAP, which requires the Company to allocate income to its unvested participating securities as part of its earnings per share (“EPS”) calculations. The following table sets forth the computation of basic earnings per share using the two-class method for amounts attributable to the Company’s shares of Common Stock and Class B Common Stock (in thousands, except per share data):


   

Thirteen weeks ended

   

Thirty-nine weeks ended

 
   

May 31,

2014

   

May 25,

2013

   

May 31,

2014

   

May 25,

2013

 
                                 

Net income

  $ 30,944     $ 28,722     $ 91,053     $ 86,124  
                                 

Allocation of net income for Basic:

                               

Common Stock

  $ 24,493     $ 22,638     $ 71,971     $ 67,793  

Class B Common Stock

    6,127       5,647       17,962       16,880  

Unvested participating shares

    324       437       1,120       1,451  
    $ 30,944     $ 28,722     $ 91,053     $ 86,124  
                                 

Weighted average number of shares for Basic:

                               

Common Stock

    15,102       14,993       15,069       14,960  

Class B Common Stock

    4,722       4,675       4,701       4,656  

Unvested participating shares

    229       331       268       366  
      20,053       19,999       20,038       19,982  
                                 

Earnings per share for Basic:

                               

Common Stock

  $ 1.62     $ 1.51     $ 4.78     $ 4.53  

Class B Common Stock

  $ 1.30     $ 1.21     $ 3.82     $ 3.63  

The Company is required to calculate diluted EPS for Common Stock using the more dilutive of the following two methods:


 

 

The treasury stock method; or

 

 

 

The two-class method assuming a participating security is not exercised or converted.


For the thirteen and thirty-nine weeks ended May 31, 2014, the Company’s diluted EPS assumes the conversion of all vested Class B Common Stock into Common Stock and uses the two-class method for its unvested participating shares. The following table sets forth the computation of diluted earnings per share of Common Stock for the thirteen and thirty-nine weeks ended May 31, 2014 as follows (in thousands, except per share data):


   

Thirteen weeks

ended May 31, 2014

   

Thirty-nine weeks

ended May 31, 2014

 
   

Earnings

to Common

Shareholders

   

Common

Shares

   

EPS

   

Earnings

to Common

Shareholders

   

Common

Shares

   

EPS

 
                                                 

As reported - Basic

  $ 24,493       15,102     $ 1.62     $ 71,971       15,069     $ 4.78  
                                                 

Add: effect of dilutive potential common shares

                                               

Share-based awards

          153                     151          

Class B Common Stock

    6,127       4,722               17,962       4,701          
                                                 

Add: Undistributed earnings allocated to unvested participating shares

    317                     1,095                
                                                 

Less: Undistributed earnings reallocated to unvested participating shares

    (300

)

                  (1,036

)

             
                                                 

Diluted EPS – Common Stock

  $ 30,637       19,977     $ 1.53     $ 89,992       19,921     $ 4.52  

Share-based awards that would result in the issuance of 168 shares of Common Stock were excluded from the calculation of diluted earnings per share for the thirteen weeks ended May 31, 2014 because they were anti-dilutive. Share-based awards that would result in the issuance of 193 shares of Common Stock were excluded from the calculation of diluted earnings per share for the thirty-nine weeks ended May 31, 2014 because they were anti-dilutive.


For the thirteen and thirty-nine weeks ended May 25, 2013, the Company’s diluted EPS assumes the conversion of all vested Class B Common Stock into Common Stock and uses the two-class method for its unvested participating shares. The following table sets forth the computation of diluted earnings per share of Common Stock for the thirteen and thirty-nine weeks ended May 25, 2013 as follows (in thousands, except per share data):


   

Thirteen weeks

ended May 25, 2013

   

Thirty-nine weeks

ended May 25, 2013

 
   

Earnings

to Common

Shareholders

   

Common

Shares

   

EPS

   

Earnings

to Common

Shareholders

   

Common

Shares

   

EPS

 
                                                 

As reported - Basic

  $ 22,638       14,993     $ 1.51     $ 67,793       14,960     $ 4.53  
                                                 

Add: effect of dilutive potential common shares

                                               

Share-based awards

          152                     135          

Class B Common Stock

    5,647       4,675               16,880       4,656          
                                                 

Add: Undistributed earnings allocated to unvested participating shares

    426                     1,415                
                                                 

Less: Undistributed earnings reallocated to unvested participating shares

    (404

)

                  (1,341

)

             
                                                 

Diluted EPS – Common Stock

  $ 28,307       19,820     $ 1.43     $ 84,747       19,751     $ 4.29  

Share-based awards that would result in the issuance of 27,347 shares of Common Stock were excluded from the calculation of diluted earnings per share for the thirteen weeks ended May 25, 2013 because they were anti-dilutive. There were no share-based awards that were excluded from the calculation of diluted earnings per share for the thirty-nine weeks ended May 25, 2013 because they were anti-dilutive.